Articles

NIMH collaborative multisite multimodal treatment study of ADHD. Richters, J. Journal of the American Academy of Child and Adolescent Psychiatry 34 (1995):987-1000.

3-year followup of the NIMH MTA Study. Jensen, P. Journal of the American Academy of Child and Adolescent Psychiatry 46 (2007):989-1002.

MTA at 8 years. Molina, B. Journal of the American Academy of Child and Adolescent Psychiatry 48 (2009):484-500.

Selective serotonin reuptake inibitors in childhood depression. Whittington, C. The Lancet 363 (2004):1341-5.

Depressing research. Editorial, The Lancet 363 (2004):1335.

Efficacy and safety of antidepressants for children and adolescents. Jureidini, J. British Medical Journal 328 (2004):879-83.

Psychotic side effects of stimulants. Cherland, E. Canadian Journal of Psychiatry 44 (1999):811-3.

Prior stimulant treatment in adolescents with bipolar disorder. DelBello, M. Bipolar Disorders 3 (2001):53-57.

Attention-deficit hyperactivity disorder and juvenile mania. Biederman, J. Journal of the American Academy of Child and Adolescent Psychiatry 35 (1996):997-1008.

Pediatric-onset bipolar disorder.Faeeda, G. Harvard Review of Psychiatry 3 (1995):171-95.

Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Geller, B. American Journal of Psychiatry 158 (2001):125-7.

Antidepressant exposure in bipolar children. Cicero, D. Psychiatry 66 (2003):317-22.

Pediatric bipolar disorder. Faedda, G. Bipolar Disorders 6 (2004):305-13.

Treatment-emergent mania in pediatric bipolar disorder. Faedda, G. Journal of Affective Disorders 82 (2004):149-58.

Long-term implications of early onset in bipolar disorder. Perlis, R. Biological Psychiatry 55 (2002):875-81.

Course and outcome of bipolar spectrum disorder in children and  adolescents_ A review of the existing literature.  Birmaher, B. Development and Psychophathology 18 (2006):1023-35.

Twelve-month outcome of adolescents with bipolar disorder following first hospitalization for a manic or mixed episode. DelBello, M. American Journal of Psychiatry 164 (2007):582-90.

Psychosocial functioning among bipolar youth. Goldstein, T. Journal of Affective Disorders 114 (2009):174-83.

Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. American Journal of Psychiatry 159 (2002):927-33.

One Year After Discharge. Schooler, N.  American Journal of Psychiatry 123 (1967): 986-995.

Relapse in Chronic Schizophrenics Following Abrupt Withdrawal of Tranquilizing Medication.  Prien, R. British Journal of Psychiatry 115 (1968): 679-86. 

Discontinuation of Chemotherapy for Chronic Schizophrenics. Prien, R. Hospital and Community Psychiatry 22 (1971): 20-23.

Comparison of Two Five-Year Follow-up Studies. Bockoven, J. American Journal of Psychiatry 132 (1975): 796-801. 

The Treatment of Acute Schizophrenia Without Drugs.  Carpenter, W. American Journal of Psychiatry 134 (1977): 14-20. 

Are There Schizophrenics for Whom Drugs May be Unnecessary or Contraindicated? Rappaport, M. International Pharmacopsychiatry 13 (1978):100-111.

A Non-Neuroleptic Treatment for Schizophrenia. Mathews, S. Schizophrenia Bulletin 5 (1979), 322-332.

Community Residential Treatment for Schizophrenia. Mosher, L. Hospital and Community Psychiatry 29 (1978), 715-723  

The Treatment of Acute Psychosis Without Neuroleptics. Mosher, L.  International Journal of Social Psychiatry 41 (1995), 157-173.

Treatment of Acute Psychosis Without Neuroleptics. Bola, J.  The Journal of Nervous and Mental Disease 191 (2003):219-229.

 Maintenance Antipsychotic Therapy. Cole, J. American Journal of Psychiatry 132 (1977): 32-6.

 Dopaminergic Supersensitivity After Neuroleptics.  Muller, P. Psychopharmacology 60 (1978):1-11.

Neuroleptic-Induced Supersensitivity Psychosis: Chouinard, G. American Journal of Psychiatry 135 (1978):1409-1410.

Neuroleptic-Induced Supersensitivity Psychosis: Chouinard, G. American Journal of Psychiatry 137 (1980):16-20.

Neuroleptic-inducedsupersensitivity psychosis, the “hump course,” and tardive dyskinesia. Chouinard, G. Journal of Clinical Psychopharmacology 2 (1982):143-4.  

The International Pilot Study of Schizophrenia. Leff, J. Psychological Medicine 22 (1992):131-145.

Schizophrenia: Manifestations, Incidence and Course in Different Cultures. Jablensky, A. Psychological Medicine, supplement 20 (1992):1-95.

Course of depressive symptoms over followup. Shea, M. Archives of General Psychiatry 49 (1992):782-87.

Do antidepressant and antianxiety drugs increase chronicity in affective disorders? Fava, G. Psychotherapy and Psychosomatics 61 (1994):125-31.

Can long-term treatment with antidepressant drugs worsen the course of depression?  Fava, G. Journal of Clinical Psychiatry 64 (2003):123-33.

Holding on, depression, sensitization by antidepressant drugs, and the prodigal experts.  Fava, G. Psychotherapy and Psychosomatics 64 (1995):57-61.

Potential sensitising effects of antidepressant drugs on depression. Fava, G. CNS Drugs 12 (1999): 247-56.

Risks and implications of interrupting maintenance psychotropic drug therapy. Baldessarini, R. Psychotherapy and Psychosomatics 63 (1005):137-41.

Can long-term andtidepressant use by depressogenic.  El-Mallakh, R. Journal of Clinical Psychiatry 60 (1999):263.

Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness.  Judd, L. American Journal of Psychiatry 157 (2000):1501-4.

One-year clinical outcomes of depressed public sector outpatients. Rush, J. Biological Psychiatry 56 (2004):46-53.

The Star D Project Results. Warden, D.  Current Psychiatry Reports 9 (2007):449-59.

Outcome of anxiety and depressive disorders in primary care.  Ronalds, C. British Journal of Psychiary 171 (1997): 427-3.

Treatment of depression related to recurrence. Weel-Baumgarten, E. Journal of Clinical Pharmacy and Therapeutics 25 (2000):61-6.

The impact of antidepressant treatment on population health. Patten, S. Population Health Metrics 2 (2004):9-16.

The effects of detection and treatment on the outcome of major depressoin in primary care.  Goldberg, D. British Journal of General Practice 48 (1998):1840-4.

Pattern of antidepressant use and duration of depresson-related absence from work. Dewa, S. British Journal of Psychiatry 183 (2003):507-13.

Characteristics and significance of untreated major depressive disorder. Coryell, W. American Journal of Psychiatry 152 (1995):1124-9.

The naturalistic course of major depression in the absence of somatic therapy.  Posternak, M. Journal of Nervous and Mental Disease 194 (2006):324-9.

Physical activity, exercise, depression and anxiety disorders. Strohle, A. Journal of Neural Transmission 116 (2009):777-84.

Breggin, Peter (1999). Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanism of action. International Journal of Risk & Safety in Medicine, 12, 3-35.
more info >>

Breggin, Peter (2003/04). Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs). International Journal of Risk & Safety in Medicine, 16, 31-49.
more info >>

Breggin, Peter (2004). "Recent U.S., Canadian and British Regulatory Agency Actions Concerning Antidepressant-Induced Harm o Self and Others: A Review and Analysis." International Journal of Risk and Safety in Medicine, 16, 247-259.
more info >>

Breggin, P. (2000).  What Psychologists and Psychotherapists Need to Know About ADHD and Stimulants. Changes: An International Journal of Psychology and Psychotherapy, 18, 13-23.

Breggin, P. (2000).  The NIMH Multimodal Study of Treatment for Attention-Deficit/Hyperactivity Disorder: A Critical Analysis.  International Journal of Risk and Safety in Medicine, 13, 15-22.  Originally published in Ethical Human Sciences and Services, 2, 63-72.

Breggin, P. (2000).  Confirming the Hazards of Stimulant Drug Treatment.  The International Journal of Risk and Safety In Medicine, 13,199-120. Originally published in Ethical Human Sciences and Services, 2, 203-204.

Breggin, P. (2000).  The Psychiatric Drugging of Toddlers.  Ethical Human Sciences and Services, 2, 83-86.

Breggin, P. (1999).  NIH Consensus Report Highlights Controversy Surrounding ADHD Diagnosis and Stimulant Treatment.  Ethical Human Sciences and Services, 1, 9-11.

Healy, D. & Le Noury J. (2007).  Pediatric bipolar disorder: An object of study in the creation of an illness. International Journal of Risk & Safety in Medicine, 19, 209–221.

Henderson, T.A. & Hartman, K. (2004).  Aggression, Mania and Hypomania Induction Associated With Atomoxetine (Strattera).  Pediatrics,114(3), 895-896.

Joseph, J. (2000). Problems in psychiatric genetic research: A reply to Faraone and Biederman. Developmental Review, 20, 582-593.

Joseph, J. (2002). Twin studies in psychiatry and psychology: Science or pseudoscience? Psychiatric Quarterly, 73, 71-82.

Joseph, J. (2000). Not in their genes: A critical view of the genetics of attention-deficit hyperactivity disorder. Developmental Review, 20, 539-567.

Lacasse, Jeffrey & Leo, Jonathan (2005). Serotonin and Depression: A Disconnect between the Advertisments and the Scientific Literature. PLoS Medicine, 2 (12), 1-6. www.plosmedicine.org
more info >>

Lambert, N. (2002).  Stimulant Treatment as a Risk Factor for Nicotine Use and Substance Abuse.  In Jensen, P . S. & Cooper, J . R. (Eds.)., Attention Deficit Hyperactivity Disorder: State of the Science; Best Practices, (pp 18-1 to 18-24) Kingston, NJ : Civic Research Institute.

Lehman, P. (2002).  Treatment-induced Suicide: Suicidality as a potential effect of psychiatric drugs.  Journal of Critical Psychology, Counseling and Therapy, 2 (1).

Leo, Jonathan & Cohen, David (2003). Broken Brains or Flawed Studies? A Critical Review of ADHD Neuroimaging Research. The Journal of Mind and Behavior, 24(1), 29-56.
more info >>

Leo, J. & Lacasse, J.R. (2007).  The Media and the Chemical Imbalance Theory of Depression.  Springer Science.

McKay M. (2007).  Forced Drugging of Children in Foster Care: Turning Child Abuse Victims into Involuntary Psychiatric Patients.  JOM, 22 (2).

Turner, E., Matthews, A., Linardatos, E., Tell, R., & Rosenthal, R. (2008).  Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy.  New England Journal of Medicine, 358 (3), 252-260. 

Washington, W., Human R., Zimbardo, P., & Antonuccio, D. (2007).  Corporate Funding and Conflicts of Interest: A Primer for Psychologists.  American Psychologist (December 2007).

Whitaker, R. (2004).  The Case Against Antipsychotic Drugs: A 50-Year Record of Doing More Harm Than Good.  Medical Hypotheses, 62, 5-13.

Whitaker, R. (2005).  Anatomy of an Epidemic:  Psychiatric Drugs and the Astonishing Rise of Mental Illness in America. Ethical Human Psychology and Psychiatry, 7, 23-35.